These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 648737)

  • 1. Plasma potassium in hypertensive Africans on frusemide.
    Adu D; Nkrumah KN; Larbi EB; Pobee JO; Adjei DO
    J Int Med Res; 1978; 6(3):207-12. PubMed ID: 648737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect on plasma potassium of a combined preparation of frusemide and slow-release potassium chloride (Diumide-K Continus tablets).
    Lewis JG
    J Int Med Res; 1979; 7(5):354-9. PubMed ID: 499643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pilot randomised double-blind controlled trial of high-dose spironolactone in critically ill patients receiving a frusemide infusion.
    Apte Y; Bellomo R; Warrillow S; Goldsmith D; Gillies M; McGain F
    Crit Care Resusc; 2008 Dec; 10(4):306-11. PubMed ID: 19049481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amiloride, spironolactone, and potassium chloride in thiazide-treated hypertensive patients.
    Ramsay LE; Hettiarachchi J; Fraser R; Morton JJ
    Clin Pharmacol Ther; 1980 Apr; 27(4):533-43. PubMed ID: 7357812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Some aspects of diuretic therapy.
    Rowe WS
    Med J Aust; 1975 Mar; 1(12):392-4. PubMed ID: 1143129
    [No Abstract]   [Full Text] [Related]  

  • 6. Significance of hypokalaemia due to diuretics.
    Leemhuis MP; Struyvenberg A
    Neth J Med; 1973; 16(1):18-28. PubMed ID: 4572424
    [No Abstract]   [Full Text] [Related]  

  • 7. A study of two diuretic/potassium combinations in heart failure.
    Hussain M; Walton K; Davidson C; Morgan DB
    Postgrad Med J; 1985 Jan; 61(711):29-33. PubMed ID: 3991397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of resistant hypertension: aldosterone antagonists or intensification of diuretic therapy?
    Verdalles U; García de Vinuesa S; Goicoechea M; Macías N; Santos A; Perez de Jose A; Verde E; Yuste C; Luño J
    Nephrology (Carlton); 2015 Aug; 20(8):567-71. PubMed ID: 25818266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the effect of combined frusemide and controlled-release potassium tablets (Diumide-K continus tablets) and frusemide and slow-K tablets in elderly patients with cardiac failure.
    Rao CR
    J Int Med Res; 1982; 10(5):357-60. PubMed ID: 6754508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adequacy of twice daily dosing with potassium chloride and spironolactone in thiazide treated hypertensive patients.
    Toner JM; Brawn LA; Yeo WW; Ramsay LE
    Br J Clin Pharmacol; 1991 Apr; 31(4):457-61. PubMed ID: 2049255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation by spironolactone of the magnesiuric effect of acute frusemide administration in patients with liver cirrhosis and ascites.
    Stergiou GS; Mayopoulou-Symvoulidou D; Mountokalakis TD
    Miner Electrolyte Metab; 1993; 19(2):86-90. PubMed ID: 8377729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total body potassium in long-term frusemide therapy: is potassium supplementation necessary?
    Dargie HJ; Boddy K; Kennedy AC; King PC; Read PR; Ward DM
    Br Med J; 1974 Nov; 4(5940):316-9. PubMed ID: 4215534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
    Saito M; Takada M; Hirooka K; Isobe F; Yasumura Y
    J Clin Pharm Ther; 2005 Dec; 30(6):603-10. PubMed ID: 16336294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Editorial: Diuretics.
    Rose JC
    Am Fam Physician; 1975 Jan; 11(1):57. PubMed ID: 1109538
    [No Abstract]   [Full Text] [Related]  

  • 15. Low dose, twice daily captopril and frusemide: a safe, effective and flexible third line treatment regimen for hypertension.
    Rademaker M; Corrie J; Lindsay BA; Flapan AD; Padfield PL
    J Hum Hypertens; 1989 Jun; 3(3):173-7. PubMed ID: 2671368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term treatment with slow-release frusemide compared with thiazide treatment in arterial hypertension.
    Jørgensen H; Anderssen N; Silsand T; Peterson LE
    J Int Med Res; 1989; 17(6):552-9. PubMed ID: 2628132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renin levels and spironolactone treatment in general practice: similar blood pressure lowering effect of spironolactone in low and normal renin patients.
    Sundsfjord JA; Odegaard AE
    Eur J Clin Invest; 1977 Oct; 7(5):389-92. PubMed ID: 411668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High dose frusemide in the treatment of hypertension in chronic renal insufficiency and of terminal renal failure.
    Rastogi SP; Volans G; Elliott RW; Eccleston DW; Ashcroft R; Webster D; Kerr DN
    Postgrad Med J; 1971 Apr; 47():Suppl:45-53. PubMed ID: 5579771
    [No Abstract]   [Full Text] [Related]  

  • 19. An open, randomized comparative study of a low-strength frusemide/amiloride combination and bumetanide/potassium chloride in the treatment of mild congestive cardiac failure.
    Latta D; Finnamore VP; Dalton K; Allman S
    J Int Med Res; 1990; 18 Suppl 2():10B-16B. PubMed ID: 2193839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic assessment of Slow-K and K-tab potassium chloride formulations in hypertensive patients treated with thiazide diuretics.
    Skoutakis VA; Carter CA; Acchiardo SR
    Drug Intell Clin Pharm; 1987 May; 21(5):445-50. PubMed ID: 3556129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.